Proteinase inhibitors in portasystemic shunts.
D000614:Aminocaproates / Q000494:pharmacology*; D007611:Aprotinin / Q000494:pharmacology* / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000201:enzymology; D001803:Blood Transfusion; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery; D011168:Portal System / Q000601:surgery*; D011183:Postoperative Complications; D013997:Time Factors
D000614:Aminocaproates; D005340:Fibrinogen; D007611:Aprotinin